Rockwell Medical, Inc. (RMTI) income statement
RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3081% below fair value
$6.26+0.16 (+2.62%)
Close on Nov 19, 2026Market cap $25.23MP/E –Yield –
Rockwell Medical, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 17.7%
- Operating margin
- -6.5%
- Net margin
- -7.3%
- Return on equity, FY2025
- -15.3%
Financial strength
- Current ratio
- 3.25
- Debt to equity
- 0.26
- Debt to assets
- 15.9%
- Cash to current liabilities
- 94.1%
Valuation
- P/E ratio
- –
- Price to sales
- 0.36
- Price to book
- 0.72
- Dividend yield
- –
See a number that looks wrong?